April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

Reason for the Shortage • Mylan Institutional has diphenhydramine injection on shortage due to increased demand. The company is increasing production to try to meet this demand. • Hospira discontinued diphenhydramine iSecure syringes in 2011. • West-Ward could not provide a reason for the shortage. • Pfizer discontinued all Benadryl injection in 2005. • IMS discontinued diphenhydramine injection in April 2008. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=845 Source: www.ashp.org Dextrose Injection 50% March 29, 2012 Products Affected - Description Dextrose Injection 50%, Hospira 50 mL vial, 25 count (NDC 00409-6648-02) Reason for the Shortage • Hospira states the shortage is due to manufacturing delays. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=621 Source: www.ashp.org Desmopressin Injection March 29, 2012 Products Affected - Description Desmopressin injection, 4 mcg/mL, Ferring 1 mL vial (NDC 55566-5030-01) 10 mL multi-dose vial (NDC 55566-5040-01) Desmopressin injection, 4 mcg/mL, Hospira 1 mL vial (NDC 00409-2265-01) Desmopressin injection, 4 mcg/mL, Teva 1 mL vial (NDC 00703-5051-03) 10 mL multi-dose vial (NDC 00703-5054-01) DDAVP, 4 mcg/mL, Sanofi 1 mL vial (NDC 00075-2451-01) 10 mL vial (NDC 00075-2451-53) Reason for the Shortage • Ferring cannot provide a reason for the shortage. • Teva and Hospira have desmopressin injection on shortage due to manufacturing delays. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=658 Source: www.ashp.org Ammonium Chloride Injection March 29, 2012 Products Affected - Description Ammonium chloride injection, Hospira 5 mEq/mL, 20 mL vial (NDC 00409-6043-01) Reason for the Shortage • Hospira states the shortage of ammonium chloride is due to manufacturing delays. • Hospira is the sole manufacturer of ammonium chloride injection. 74
Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=686 Source: www.ashp.org Metoprolol Injection March 30, 2012 Products Affected - Description Metoprolol 1 mg/mL Injection, American Regent 5 mL vial, 25 count (NDC 00517-1355-25) Metoprolol 1 mg/mL Injection, APP 5 mL vial, 10 count (NDC 63323-0660-05) Metoprolol 1 mg/mL Injection, Bedford 5 mL vial, 10 count (NDC 55390-0073-10) 5 mL Novaplus vial, 10 count (NDC 55390-0348-10) Metoprolol 1 mg/mL Injection, Hospira 5 mL Carpuject syringe, 3 count (NDC 00409-1778-35) 5 mL ampule, 12 count (NDC 00409-2285-05) 5 mL vial (NDC 00409-1778-05) Metoprolol 1 mg/mL Injection, Sagent 5 mL vial (NDC 25021-0303-05) Reason for the Shortage • American Regent had temporarily suspended manufacture of most drug products including metoprolol in April, 2011. • The company Regent resumed manufacturing in Shirley, New York in early-May, 2011. • APP and Hospira state the shortage is due to increased demand for the product. • Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011 on a temporary basis for maintenance and requalification of equipment. Product will become available in stages as production resumes. • Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories manufactured products. Availability of products is updated on the Bedford Laboratories website - select “Customer supply update report”. • Sagent has metoprolol injection on shortage due to increased demand for the product. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=813 Source: www.ashp.org Methazolamide Tablets March 30, 2012 Products Affected - Description Methazolamide Tablets, Fera 25 mg tablets, 100 count (NDC 48102-0100-01) 50 mg tablets, 100 count (NDC 48102-0101-01) Methazolamide Tablets, Sandoz 25 mg tablets, 100 count (NDC 00781-1072-01) 50 mg tablets, 100 count (NDC 00781-1071-01) Reason for the Shortage • Fera cannot provide a reason for the shortage. • Sandoz cannot provide a reason for the shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=901 Source: www.ashp.org 75
Page 1 and 2:
April 2012 Drug Information Update
Page 3 and 4:
First-Time Generics GENERIC DRUG NA
Page 5 and 6:
GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8:
Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10:
Statin Drugs - Drug Safety Communic
Page 11 and 12:
Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14:
low blood sugar (hypoglycemia) in p
Page 15 and 16:
Some women with depression who beco
Page 17 and 18:
Survival increased for all groups o
Page 19 and 20:
finding that it also may reduce the
Page 21 and 22:
Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57 and 58: • Ben Venue voluntarily suspended
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72: • Teva discontinued all ciproflox
Page 73: Nicardipine hydrochloride injection
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?